Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention

  Rheumatoid Arthritis

  Free Subscription


13.03.2023

1 Ann Rheum Dis
2 Arthritis Res Ther
1 Clin Exp Immunol
9 J Rheumatol
2 PLoS One
6 Z Rheumatol


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Rheum Dis

  1. HUSS V, Bower H, Hellgren K, Frisell T, et al
    Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study.
    Ann Rheum Dis. 2023 Mar 3:ard-2022-223636. doi: 10.1136/ard-2022-223636.
    PubMed         Abstract available


    Arthritis Res Ther

  2. LIU B, Wang J, Li YY, Li KP, et al
    The association between systemic immune-inflammation index and rheumatoid arthritis: evidence from NHANES 1999-2018.
    Arthritis Res Ther. 2023;25:34.
    PubMed         Abstract available

  3. DE MOEL EC, Trouw LA, Terao C, Govind N, et al
    Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populations.
    Arthritis Res Ther. 2023;25:37.
    PubMed         Abstract available


    Clin Exp Immunol

  4. CHO S, Jang E, Yoon T, Hwang H, et al
    A novel selective spleen tyrosine kinase inhibitor SKI-O-703 (cevidoplenib) ameliorates lupus nephritis and serum-induced arthritis in murine models.
    Clin Exp Immunol. 2023;211:31-45.
    PubMed         Abstract available


    J Rheumatol

  5. HANLY JG, Lethbridge L
    Use of Disease-modifying Antirheumatic Drugs, Biologics, and Corticosteroids in Older Patients With Rheumatoid Arthritis Over 20 Years.
    J Rheumatol. 2021;48:977-984.
    PubMed         Abstract available

  6. BOERS M, Pincus T
    Long-term Glucocorticoid Use in Rheumatoid Arthritis.
    J Rheumatol. 2021;48:1342.
    PubMed        

  7. VU M, Carvalho N, Clarke PM, Buchbinder R, et al
    Impact of Comorbid Conditions on Healthcare Expenditure and Work-related Outcomes in Patients With Rheumatoid Arthritis.
    J Rheumatol. 2021;48:1221-1229.
    PubMed         Abstract available

  8. SAFY-KHAN M, de Hair MJH, Welsing PMJ, van Laar JM, et al
    Current Smoking Negatively Affects the Response to Methotrexate in Rheumatoid Arthritis in a Dose-responsive Way, Independently of Concomitant Prednisone Use.
    J Rheumatol. 2021;48:1504-1507.
    PubMed         Abstract available

  9. CHATZIDIONYSIOU K, Hetland ML, Frisell T, Di Giuseppe D, et al
    Effectiveness of a Second Biologic After Failure of a Non-tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis.
    J Rheumatol. 2021;48:1512-1518.
    PubMed         Abstract available

  10. BEAUMONT JL, Davis ES, Curtis JR, Cella D, et al
    Meaningful Change Thresholds for Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue and Pain Interference Scores in Patients With Rheumatoid Arthritis.
    J Rheumatol. 2021;48:1239-1242.
    PubMed         Abstract available

  11. FOX RI, Fox CM
    Axial Articular Manifestations in Primary Sjogren Syndrome: Have We Been Missing Spondyloarthritis for All This Time?
    J Rheumatol. 2021;48:963-964.
    PubMed        

  12. RIPSMAN DA, Bookman AAM
    Correlation Between Subjective and Objective Severity of Oral and Ocular Dryness in Primary Sjogren Syndrome.
    J Rheumatol. 2021;48:1290-1294.
    PubMed         Abstract available

  13. CHEN YW, Tsai PY, Wei JC
    Lymphoma and Sjogren Syndrome: A Common Overlapping Syndrome?
    J Rheumatol. 2021;48:1343.
    PubMed        


    PLoS One

  14. TALMON M, Percio M, Obeng JA, Ruffinatti FA, et al
    Transcriptomic profile comparison of monocytes from rheumatoid arthritis patients in treatment with methotrexate, anti-TNFa, abatacept or tocilizumab.
    PLoS One. 2023;18:e0282564.
    PubMed         Abstract available

  15. CHI C, Solomon O, Shiboski C, Taylor KE, et al
    Identification of Sjogren's syndrome patient subgroups by clustering of labial salivary gland DNA methylation profiles.
    PLoS One. 2023;18:e0281891.
    PubMed         Abstract available


    Z Rheumatol

  16. FIEHN C, Leipe J, Weseloh C, Bergner R, et al
    [Assessment of interactions and dosage recommendations of synthetic DMARDs-Evidence-based and consensus-based recommendations based on a systematic literature search].
    Z Rheumatol. 2023;82:151-162.
    PubMed         Abstract available

  17. VORDENBAUMEN S, Feist E
    [Adult-onset Still's disease : Diagnosis and treatment according to the new S2e guidelines of the German Society of Rheumatology (DGRh)].
    Z Rheumatol. 2023;82:134-142.
    PubMed         Abstract available

  18. VORDENBAUMEN S, Feist E, Rech J, Fleck M, et al
    [DGRh S2e guidelines : Diagnostic and treatment of adult-onset Still's disease (AOSD)].
    Z Rheumatol. 2022;81.
    PubMed        

  19. VORDENBAUMEN S, Feist E, Rech J, Fleck M, et al
    [Guideline report on the DGRh S2e guidelines on diagnostics and treatment of adult-onset Still's disease (AOSD)].
    Z Rheumatol. 2022;81.
    PubMed        

  20. RATH E, Bonelli M, Duftner C, Gruber J, et al
    [National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic DMA
    Z Rheumatol. 2023;82:163-174.
    PubMed         Abstract available

  21. BARALIAKOS X, Alshakaki F, Buhring B, Andreica I, et al
    [How many patients with inflammatory rheumatic diseases have the technical prerequisites for video consultations and are also willing to use this to carry out visits by medical specialist visits?].
    Z Rheumatol. 2023;82:102-107.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: